Precision Cancer Consortium Adds New Members in Efforts to Improve Access to Comprehensive Genomic Testing for Patients with Cancer
We pleased to announce the addition of two new members, Lilly and the Janssen Pharmaceutical Companies of Johnson & Johnson.
